Plus, news about Sanofi, IGM Biosciences, Eli Lilly, Purdue University, Minghui, Qilu, Sirius Therapeutics, Keros Therapeutics, Palatin and Leo Pharma:
💉AstraZeneca touts Imfinzi Phase 3 win in high-risk bladder cancer: The company’s
↧